Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

34.38

+0.21 (0.61%)

At close: Aug 26, 2026, 4:00 PM EDT

34.40

+0.02 (0.06%)

After-hours: Aug 26, 2026, 7:53 PM EDT

Viking Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	125.75	165.81	26.68	55.52	36.63	26.37
Short-Term Investments	375.91	539.93	875.94	306.56	118.85	175.73
Cash & Short-Term Investments	501.66	705.74	902.61	362.08	155.49	202.1
Cash Growth	-37.89%	-21.81%	149.29%	132.87%	-23.07%	-18.63%
Prepaid Expenses	0.94	1.81	1.13	2.52	3.41	0.62
Other Current Assets	14.96	8.05	3.48	2.62	8.14	7.81
Total Current Assets	517.56	715.6	907.22	367.23	167.04	210.53
Property, Plant & Equipment	4.01	0.09	1	1.13	1.42	0.03
Long-Term Deferred Charges	-	-	0.06	0.11	0.04	0.08
Other Long-Term Assets	0.32	0.05	0.05	0.03	0.03	0.03
Total Assets	521.9	715.73	908.32	368.49	168.53	210.66

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	69.01	53.25	9.81	7.51	8.53	1.44
Accrued Expenses	40.48	23.28	17.11	11.3	13.11	7.31
Current Portion of Leases	0.16	0.14	0.49	0.32	0.3	0.03
Total Current Liabilities	109.66	76.67	27.41	19.14	21.95	8.78
Long-Term Leases	3.93	-	0.63	0.94	1.26	-
Total Liabilities	113.58	76.67	28.04	20.07	23.21	8.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,543	1,486	1,369	733.55	445.27	425.61
Retained Earnings	-1,134	-847.55	-487.91	-377.94	-292.05	-223.18
Treasury Stock	-	-	-	-6.8	-6.8	-
Comprehensive Income & Other	-1.15	0.38	-0.79	-0.39	-1.1	-0.55
Shareholders' Equity	408.32	639.06	880.28	348.42	145.32	201.88
Total Liabilities & Equity	521.9	715.73	908.32	368.49	168.53	210.66

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	4.09	0.14	1.12	1.26	1.56	0.03
Net Cash (Debt)	497.58	705.6	901.49	360.82	153.92	202.07
Net Cash Growth	-38.33%	-21.73%	149.85%	134.42%	-23.83%	-18.53%
Net Cash Per Share	4.34	6.26	8.27	3.82	2.00	2.62
Filing Date Shares Outstanding	116.65	115.55	112.25	100.49	78.42	78.36
Total Common Shares Outstanding	116.65	114.79	111.57	100.11	78.26	78.25
Working Capital	407.91	638.93	879.8	348.09	145.09	201.75
Book Value Per Share	3.50	5.57	7.89	3.48	1.86	2.58
Tangible Book Value	408.32	639.06	880.28	348.42	145.32	201.88
Tangible Book Value Per Share	3.50	5.57	7.89	3.48	1.86	2.58

SEC Filings: 10-K · 10-Q